Trials / Enrolling By Invitation
Enrolling By InvitationNCT06828562
GENomic Predictors in A Multi-Ethnic Population With Kidney Disease Study
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Western Sydney Local Health District · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To establish a prospective, longitudinal cohort of participants who can provide blood, tissue (including kidney histology), urine samples to establish a core biobank for kidney disease research. Results from this biobank will be matched to clinical outcomes to facilitate the discovery (and/or validation) of novel prognostic, predictive or diagnostic biomarkers important for kidney disease.
Detailed description
Hypothesis: Genetic ancestry influences the enrichment of certain polymorphisms, which may have important protective or adverse effects on important kidney related outcomes, including developing chronic kidney disease, progression to kidney failure, and/or poor long-term outcomes following kidney transplantation. Aims: To establish a prospective, longitudinal cohort of participants who can provide blood, tissue (including kidney histology), urine samples to establish a core biobank for kidney disease research. Results from this biobank will be matched to clinical outcomes to facilitate the discovery (and/or validation) of novel prognostic, predictive or diagnostic biomarkers important for kidney disease. Data from this cohort will be used to determine if genomic factors independently influence: 1. The susceptibility to developing acute kidney injury (AKI) and the severity of AKI. 2. The development of chronic kidney disease (CKD), and the complications of CKD 3. The progression to kidney failure (needing dialysis or transplant) and complications of kidney failure? 4. The risk of treatment failure (or resistance) to standard medical therapy for any of the above (1-4)?
Conditions
Timeline
- Start date
- 2025-02-10
- Primary completion
- 2040-01-01
- Completion
- 2050-01-01
- First posted
- 2025-02-14
- Last updated
- 2025-07-17
Locations
4 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT06828562. Inclusion in this directory is not an endorsement.